CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD. CareRay Digital Medical Technology Co., Ltd. Stock
Equities
688607
CNE100004BR9
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.89 CNY | -3.30% |
|
-3.88% | -36.75% |
| Sales 2023 | 274M 37.81M | Sales 2024 * | 345M 47.65M | Capitalization | 1.14B 157M |
|---|---|---|---|---|---|
| Net income 2023 | 15M 2.07M | Net income 2024 * | 29M 4.01M | EV / Sales 2023 | 6.56 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 3.29 x |
| P/E ratio 2023 |
120
x | P/E ratio 2024 * |
39.1
x | Employees | - |
| Yield 2023 |
0.26% | Yield 2024 * |
-
| Free-Float | 54.29% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.30% | ||
| 1 week | -3.88% | ||
| 1 month | -15.53% | ||
| 3 months | -5.01% | ||
| 6 months | -35.03% | ||
| Current year | -36.75% |
1 week
12.70
13.38
1 month
10.8415.21
Current year
9.7121.20
1 year
9.7122.63
3 years
9.7164.44
5 years
9.7185.22
10 years
9.7185.22
| Managers | Title | Age | Since |
|---|---|---|---|
Jian Qiang Liu
CEO | Chief Executive Officer | 62 | 07-05-22 |
Tao Guo
CHM | Chairman | 43 | 18-06-30 |
Ping Zhang
DFI | Director of Finance/CFO | 46 | 07-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jian Qiang Liu
CEO | Chief Executive Officer | 62 | 07-05-22 |
Xin Hua Jiang
BRD | Director/Board Member | 61 | 21-05-19 |
Peng Gao
BRD | Director/Board Member | 61 | 07-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 12.89 | -3.30% | 3,321,492 |
| 24-04-29 | 13.33 | -0.60% | 2,787,763 |
| 24-04-26 | 13.41 | +1.75% | 2,300,809 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes
CareRay Digital Medical Technology Co Ltd is a China-based company mainly engaged in the research and development, production, sales and service of digital X-ray flat panel detectors. The Company's product applications have gradually extended from medical general radiography to breast, dynamic fluoroscopy, radiotherapy, oral three-dimensional imaging and other fields, and further expanded to the fields of industry, security, and pet medical care. The Company's products are sold to domestic and foreign markets.
Calendar
2024-08-15
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
12.89
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -36.75% | 157M | |
| -3.25% | 15.01B | |
| -38.91% | 2.8B | |
| -12.68% | 2.45B | |
| -12.18% | 1.46B | |
| -.--% | 1.12B | |
| +46.70% | 540M | |
| +94.87% | 515M | |
| +14.96% | 249M | |
| -13.03% | 202M |
- Stock Market
- Equities
- 688607 Stock
